Comparative Cost-Effectiveness Analysis of Adding Twice-Daily Exenatide To Insulin Glargine Versus Adding Insulin Lispro To Treat Type 2 Diabetes In Spain
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.723
https://www.valueinhealthjournal.com/article/S1098-3015(14)02653-9/fulltext
Title :
Comparative Cost-Effectiveness Analysis of Adding Twice-Daily Exenatide To Insulin Glargine Versus Adding Insulin Lispro To Treat Type 2 Diabetes In Spain
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)02653-9&doi=10.1016/j.jval.2014.08.723
First page :
A349
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
144